Stock Events

Stock Events

Sangui Biotech International 

€0.003000
0
+€0.00+0% Friday 20:00

Statistics

Day High
0.003
Day Low
0.003
52W High
0.003
52W Low
0.003
Volume
30,000
Avg. Volume
0
Mkt Cap
629,706
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

21.22%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
342,725.3Revenue
72,741Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biotech firm that develops innovative human therapeutics, competing in similar biotechnological advancements and healthcare solutions as Sangui Biotech International.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is involved in the research and development of biopharmaceuticals, directly competing with Sangui Biotech in the biotech industry, particularly in areas like blood substitutes.
Biogen
BIIB
Mkt Cap32.28B
Biogen focuses on discovering, developing, and delivering worldwide innovative therapies for people living with serious neurological diseases, competing with Sangui Biotech's research and development in healthcare.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals is a leading biotechnology company that invents life-transforming medicines for people with serious diseases, competing in the same innovative healthcare solutions market as Sangui Biotech.
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Vertex Pharmaceuticals is known for creating new possibilities in medicine to cure diseases and improve people's lives, competing in the biotech sector alongside Sangui Biotech.
Incyte
INCY
Mkt Cap25.21B
Incyte Corporation specializes in oncology products, competing with Sangui Biotech in the development of treatments for medical conditions.
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
CRISPR Therapeutics is a gene editing company focused on developing gene-based medicines for serious diseases, directly competing with Sangui Biotech's innovative approach to healthcare.

About

Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds. It also offers nano formulations for the regeneration of skin, including skin moisturization and enhanced skin elasticity; Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray products under the Granulox brand name primarily in Europe and Mexico; and cosmetics products through internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.
Show more...
CEO
Mr. Thomas Striepe
Country
United States
ISIN
US80105B1017

Listings

MU
DE
SBH.MU

0 Comments

Share your thoughts

FAQ

What is Sangui Biotech International stock price today?▼
The current price of SBH.MU is €0.00 EUR — it has increased by +0% in the past 24 hours. Watch Sangui Biotech International stock price performance more closely on the chart.
What is Sangui Biotech International stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Sangui Biotech International stocks are traded under the ticker SBH.MU.
What is Sangui Biotech International market cap?▼
Today Sangui Biotech International has the market capitalization of 629,706
What is Sangui Biotech International revenue for the last year?▼
Sangui Biotech International revenue for the last year amounts to 342,725.3 EUR.
What is Sangui Biotech International net income for the last year?▼
SBH.MU net income for the last year is 72,741 EUR.
In which sector is Sangui Biotech International located?▼
Sangui Biotech International operates in the Health & Wellness sector.
When did Sangui Biotech International complete a stock split?▼
Sangui Biotech International has not had any recent stock splits.
Where is Sangui Biotech International headquartered?▼
Sangui Biotech International is headquartered in Hamburg, United States.